Search research articles
Contact Us
Filters
Showing results (781-790 of 839) with videos related to
Page
of 84
Sort By:
Clinical Chemistry
|
October 18, 2013
Flexible micro spring array device for high-throughput enrichment of viable circulating tumor cells
Ramdane A Harouaka, Ming-Da Zhou, Yin-Ting Yeh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 12, 2017
Genetic and Immune Profiles of Solid Predominant Lung Adenocarcinoma Reveal Potential Immunotherapeutic Strategies
Zhong-Yi Dong, Chao Zhang, Yu-Fa Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 30, 2018
Strong Programmed Death Ligand 1 Expression Predicts Poor Response and De Novo Resistance to EGFR Tyrosine Kinase Inhibitors Among NSCLC Patients With EGFR Mutation
Shan Su, Zhong-Yi Dong, Zhi Xie, et al.
Gut Microbes
|
September 12, 2025
Live biotherapeutic <i>enterococcus lactis</i> MNC-168 promotes the efficacy of immune checkpoint blockade in cancer therapy by activating STING pathway via bacterial membrane vesicles
Yibo Xian, Zhipeng Chen, Zhou Lan, et al.
Nature Nanotechnology
|
September 10, 2025
Nanofibrous supramolecular peptide hydrogels for controlled release of small-molecule drugs and biologics
Brett H Pogostin, Samuel X Wu, Michael J Swierczynski, et al.
NPJ Precision Oncology
|
September 19, 2022
Induction immune-checkpoint inhibitors for resectable oncogene-mutant NSCLC: A multicenter pooled analysis
Chao Zhang, Hua-Fei Chen, Shi Yan, et al.
Clinical Lung Cancer
|
June 6, 2022
Biomarker-Driven Studies With Multi-targets and Multi-drugs by Next-Generation Sequencing for Patients With Non-Small-Cell Lung Cancer: An Open-Label, Multi-center, Phase II Adaptive Umbrella Trial and a Real-World Observational Study (CTONG1702&CTONG1705)
Si-Yang Maggie Liu, Hong-Hong Yan, Xue-Wu Wei, et al.
Journal of Cancer
|
July 11, 2019
Efficacy and safety of nimotuzumab in addition to radiotherapy and temozolomide for cerebral glioblastoma: a phase II multicenter clinical trial
Xiao-Jing Du, Xian-Ming Li, Lin-Bo Cai, et al.
Antimicrobial Agents and Chemotherapy
|
September 30, 2024
Contribution of direct InhA inhibitors to novel drug regimens in a mouse model of tuberculosis
Lourdes Encinas, Si-Yang Li, Joaquin Rullas-Trincado, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
April 16, 2024
Assessment of causal association between the socio-economic status and osteoporosis and fractures: a bidirectional Mendelian randomization study in European population
Jia-Yue Duan, Rui-Xuan You, Yong Zhou, et al.
Page
of 84
Search research articles
Search
Showing results (781-790 of 839) with videos related to
Sort By:
Page
of 84
Clinical Chemistry
|
October 18, 2013
Flexible micro spring array device for high-throughput enrichment of viable circulating tumor cells
Ramdane A Harouaka, Ming-Da Zhou, Yin-Ting Yeh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 12, 2017
Genetic and Immune Profiles of Solid Predominant Lung Adenocarcinoma Reveal Potential Immunotherapeutic Strategies
Zhong-Yi Dong, Chao Zhang, Yu-Fa Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 30, 2018
Strong Programmed Death Ligand 1 Expression Predicts Poor Response and De Novo Resistance to EGFR Tyrosine Kinase Inhibitors Among NSCLC Patients With EGFR Mutation
Shan Su, Zhong-Yi Dong, Zhi Xie, et al.
Gut Microbes
|
September 12, 2025
Live biotherapeutic <i>enterococcus lactis</i> MNC-168 promotes the efficacy of immune checkpoint blockade in cancer therapy by activating STING pathway via bacterial membrane vesicles
Yibo Xian, Zhipeng Chen, Zhou Lan, et al.
Nature Nanotechnology
|
September 10, 2025
Nanofibrous supramolecular peptide hydrogels for controlled release of small-molecule drugs and biologics
Brett H Pogostin, Samuel X Wu, Michael J Swierczynski, et al.
NPJ Precision Oncology
|
September 19, 2022
Induction immune-checkpoint inhibitors for resectable oncogene-mutant NSCLC: A multicenter pooled analysis
Chao Zhang, Hua-Fei Chen, Shi Yan, et al.
Clinical Lung Cancer
|
June 6, 2022
Biomarker-Driven Studies With Multi-targets and Multi-drugs by Next-Generation Sequencing for Patients With Non-Small-Cell Lung Cancer: An Open-Label, Multi-center, Phase II Adaptive Umbrella Trial and a Real-World Observational Study (CTONG1702&CTONG1705)
Si-Yang Maggie Liu, Hong-Hong Yan, Xue-Wu Wei, et al.
Journal of Cancer
|
July 11, 2019
Efficacy and safety of nimotuzumab in addition to radiotherapy and temozolomide for cerebral glioblastoma: a phase II multicenter clinical trial
Xiao-Jing Du, Xian-Ming Li, Lin-Bo Cai, et al.
Antimicrobial Agents and Chemotherapy
|
September 30, 2024
Contribution of direct InhA inhibitors to novel drug regimens in a mouse model of tuberculosis
Lourdes Encinas, Si-Yang Li, Joaquin Rullas-Trincado, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
April 16, 2024
Assessment of causal association between the socio-economic status and osteoporosis and fractures: a bidirectional Mendelian randomization study in European population
Jia-Yue Duan, Rui-Xuan You, Yong Zhou, et al.
Page
of 84